| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |